Stock AFIB ACUTUS MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Acutus Medical, Inc.

Equities

AFIB

US0051111096

Delayed Nasdaq
Other stock markets
 11:45:07 2024-05-02 am EDT 		5-day change 1st Jan Change
0.1525 USD -0.33% Intraday chart for Acutus Medical, Inc. -6.67% -24.47%
Apr. 04 North American Morning Briefing : Focus Turns to -2- DJ
Apr. 01 Acutus Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BTIG Adjusts Acutus Medical's Price Target to $1.50 From $2, Reiterates Buy Rating
MT
BTIG Upgrades Acutus Medical to Buy from Neutral, Sets $2 Price Target
MT
Goldman Sachs Adjusts Acutus Medical Price Target to $1 From $5, Maintains Neutral Rating
MT
BTIG Downgrades Acutus Medical to Neutral From Buy
MT
Canaccord Genuity Downgrades Acutus Medical to Hold from Buy, Adjusts Price Target to $3 from $10
MT
Canaccord Genuity Adjusts Acutus Medical's Price Target to $10 From $18, Maintains Buy Rating
MT
JPMorgan Downgrades Acutus Medical to Underweight From Neutral
MT
ACUTUS MEDICAL : Goldman Sachs Starts Actus Medical at Neutral with $10 Price Target
MT
ACUTUS MEDICAL : Canaccord Genuity Upgrades Acutus Medical to Buy From Hold; Price Target is $18
MT
ACUTUS MEDICAL : William Blair Downgrades Acutus Medical to Market Perform From Outperform
MT
ACUTUS MEDICAL : JPMorgan Downgrades Acutus Medical to Neutral From Overweight, Adjusts Price Target to $19 From $39
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AFIB Stock
  4. News Acutus Medical, Inc.
  5. Analyst Reco.